Antigenics

Visual Financials
Company Name: Agenus Inc
Ticker Symbol: AGEN
CIK Number: 0001098972
WWW Address: http://www.agenusbio.com
CEO: Dr. Garo H Armen PhD
No. of Employees: 131
Common Issue Type: CS
Business Description:Agenus, Inc. is a biotechnology company, which is developing and commercializing technologies to treat cancers and infectious diseases, based on immunological approaches.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 5.85 Down -0.2 5.85 5.95 6.08 6.29 5.83 1404823
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 508.9 87.0 0.00 -1.13 0.00 0.0 0.0 7.45 - 2.61
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close5.86$
PE Ratio - LTM0.0
Market Capitalisation508.9mil
Latest Shares Outstanding87.0mil
Earnings pS (EPS)-1.13$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee107,900$
Effective Tax Rate0.0%
Float83.2mil
Float as % of Shares Outstanding1.0%
Foreign Sales1mil
Domestic Sales24mil
Selling, General & Adm/tive (SG&A) as % of Revenue1.10%
Research & Devlopment (R&D) as % of Revenue2.80%
Gross Profit Margin100.0%
EBITDA Margin-317.3%
Pre-Tax Profit Margin-375.8%
Assets Turnover15.7%
Return on Assets (ROA)-55.6%
Return on Equity (ROE)-187.9%
Return on Capital Invested (ROCI)-82.2%
Current Ratio6.4
Leverage Ratio (Assets/Equity)3.4
Interest Cover
Total Debt/Equity (Gearing Ratio)1.62
LT Debt/Total Capital62.0%
Working Capital pS1.78$
Cash pS0.00$
Book-Value pS0.19$
Tangible Book-Value pS0.34$
Cash Flow pS-0.90$
Free Cash Flow pS-0.97$
KEY FIGURES (LTM): Price info
Price/Book Ratio30.96
Price/Tangible Book Ratio0.00
Price/Cash Flow-6.6
Price/Free Cash Flow-6.2
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---0.21,026,3383,017,419
4 Weeks6.374.844.9322.7221,165,31524,471,621
13 Weeks6.373.613.8557.1531,000,33964,021,714
26 Weeks6.372.652.85112.7991,085,570138,953,073
52 Weeks7.452.616.91-12.4-251,113,765281,782,682
YTD6.372.61-36.0281,103,581179,883,786
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
5.996.025.014.144.180.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.491.00.16
Income0.0
Dividend0.0
Capital SpendingNA
R&D-14.54NA-12.40
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %-91.7-91.7479.2
Earnings %0.00.00.0
EPS %-100.0-100.00.0
EPS $-0.64-0.640.70
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio64.06
Current Ratio6.4
Quick Ratio (Acid Test)6.3
Liquidity Ratio (Cash)10.66
Receivables Turnover5.1
Average Collection Period71
Working Capital/Equity219.4
Working Capital pS1.79
Cash-Flow pS-0.60
Free Cash-Flow pS-0.65
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio1.09
Financial Leverage Ratio (Assets/Equity)1.6
Debt Ratio47.3
Total Debt/Equity (Gearing Ratio)1.62
LT Debt/Equity1.62
LT Debt/Capital Invested77.0
LT Debt/Total Liabilities99.9
Interest Cover0.0
Interest/Capital Invested0.00
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio2.16
Current P/E Ratio - LTM0.00
Enterprise Value (EV)/EBITDA-4.90
Enterprise Value (EV)/Free Cash Flow-4.71
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM30.96
Price/Cash Flow Ratio-6.6
Price/Free Cash Flow Ratio - LTM-6.2
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM0.0
P/E Ratio (26 weeks ago) - LTM0.0
P/E Ratio (52 weeks ago) - LTM0.0
5-Y High P/E Ratio-10.3
5-Y Low P/E Ratio-1.9
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM0.0
PER SHARE FIGURES
LT Debt pS1.88
Current Liabilities pS0.47
Tangible Book Value pS - LTM0.34
Book Value pS - LTM0.19
Capital Invested pS2.13
Cash pS - LTM0.00
Cash Flow pS - LTM-0.90
Free Cash Flow pS - LTM-0.97
Earnings pS (EPS)-1.13
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin-204.56
Free Cash Flow Margin 5YEAR AVG-415.88
Net Profit Margin-3.3
Net Profit Margin - 5YEAR AVRG.-6.0
Equity Productivity0.35
Return on Equity (ROE)-1.9
Return on Equity (ROE) - 5YEAR AVRG.
Capital Invested Productivity0.13
Return on Capital Invested (ROCI)0.0
Return on Capital Invested (ROCI) - 5YEAR AVRG.
Assets Productivity0.20
Return on Assets (ROA)-0.6
Return on Assets (ROA) - 5YEAR AVRG.-0.8
Gross Profit Margin100.0
Gross Profit Margin - 5YEAR AVRG.1.0
EBITDA Margin - LTM-317.3
EBIT Margin - LTM-325.2
Pre-Tax Profit Margin0.0
Pre-Tax Profit Margin - 5YEAR AVRG.
Effective Tax Rate0.0
Effective Tax Rate - 5YEAR AVRG.0.0
EFFICIENCY RATIOS
Cash Conversion Cycle135,984
Revenue per Employee107,900
Net Income per Employee
Average Collection Period135,984
Receivables Turnover5.1
Day's Inventory Turnover Ratio
Inventory Turnover0.0
Inventory/Sales0.4
Accounts Payble/Sales18.09
Assets/Revenue5.00
Net Working Capital Turnover0.16
Fixed Assets Turnover0.43
Total Assets Turnover0.2
Revenue per $ Cash0.18
Revenue per $ Plant1.62
Revenue per $ Common Equity0.35
Revenue per $ Capital Invested0.13
Selling, General & Adm/tive (SG&A) as % of Revenue114.3
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue283.9
R&D Expense as % of Revenue - 5YEAR AVRG.283.9

  
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:32 V:us D:20160825 06:19:47